INTERNATIONAL FLAVORS & FRAGRANCES (IFF) Company Report

The Colibri robot can produce 200 sample batches in eight hours, four times faster than the previous system.
The system handles multiple ingredients simultaneously, enhancing automation and expediting fragrance prototyping.
Installation at the Chin Bee facility is part of IFF’s $30 million Singapore Innovation Centre investment, reflecting commitment to the fast-growing Greater Asia market.
Despite technological gains, IFF shows an Altman Z-Score of 1.2 and a price-to-book ratio of 1.21, suggesting potential financial distress alongside modest stock undervaluation.

Nov 24, 2025, 1:05 AM

Morningstar

IFF installs green hydrogen production facility in Spain

IFF

Product Launch

New Projects/Investments

Guidance Update

IFF has launched a nature-based green hydrogen facility at its Benicarló, Spain site, the first in the fragrance industry to use renewable electricity for hydrogenation processes.
Developed in partnership with Iberdrola, the facility produces 100 tons of clean hydrogen annually via solar power, reducing CO₂ emissions by about 2,000 tons per year.
The green hydrogen supports hydrogenation for over 50 key fragrance ingredients, including Cashmeran and Kharismal, replacing traditional gray hydrogen.
IFF reaffirmed its FY 2025 guidance projecting up to 4% currency-neutral sales growth, as it continues efforts to recover volumes and margins.

Nov 6, 2025, 8:07 PM

Morningstar

IFF installs on-site green hydrogen production facility at Benicarló site

IFF

New Projects/Investments

IFF partnered with Iberdrola to install the fragrance industry's first nature-based green hydrogen production facility at its Benicarló, Spain plant, capable of producing 100 tons of clean hydrogen annually for on-site hydrogenation reactions.
Powered by solar energy, the facility eliminates 2,000 tons of CO₂ emissions per year, supporting IFF’s goal to cut scope 1 and 2 emissions by 50% and scope 3 by 30% by 2030, with net-zero operations targeted by 2040.
The green hydrogen is used in hydrogenation processes for over 50 key fragrance ingredients, including Cashmeran and Kharismal.
This project is part of a 10-year renewable hydrogen energy agreement with Iberdrola and will serve as a blueprint for sustainable innovation across IFF’s global manufacturing network.

Nov 6, 2025, 8:00 AM

Press Release

IFF announces Q3 2025 results

IFF

Earnings

Guidance Update

Share Buyback

IFF delivered $2.7 billion in third-quarter revenue, flat year-over-year against a strong 9% prior comparable, and reported adjusted operating EBITDA of $519 million, up 7%, with margin expanding 130 bps to 19.3%.
By segment, taste sales rose 2% to $635 million, food ingredients revenue fell 3% to $830 million while its adjusted EBITDA jumped 24% to $106 million, health & biosciences sales were flat at $577 million, and scent sales grew 5% to $652 million.
The company reiterated full-year 2025 guidance, expecting sales of $10.6–$10.9 billion and adjusted operating EBITDA of $2.0–$2.15 billion, targeting low-end comparable sales growth of 1–4% and mid-point EBITDA growth of 5–10%.
IFF’s balance sheet showed free cash flow of $126 million in Q3, cash of $621 million, gross debt of $6 billion, net debt to credit-adjusted EBITDA at 2.5×, and a $500 million share repurchase authorization in place.

Nov 5, 2025, 2:00 PM

Transcript

IFF reports Q3 2025 results

IFF

Earnings

Guidance Update

Share Buyback

IFF delivered Q3 revenue of $2.7 billion (flat vs. prior-year 9% comparable) and adjusted operating EBITDA of $519 million (+7%), lifting margin to 19.3% (+130 bps).
Scent sales grew 5% to $652 million and Taste sales grew 2% to $635 million, offsetting a 3% decline in Food Ingredients and flat sales in Health & Biosciences.
Reiterated full-year 2025 guidance: sales of $10.6 billion–$10.9 billion and adjusted operating EBITDA of $2.0 billion–$2.15 billion, aiming for low-end sales growth (1%–4%) and mid-point EBITDA growth (5%–10%).
Strengthened the balance sheet with net debt at 2.5× EBITDA, cash of $621 million, and initiated a $500 million share repurchase program.
Advanced strategic investments, opening a scent creative center in Dubai and a citrus innovation center in Florida, and forming collaborations with BASF and Kemira on DEB biopolymer technology.

Nov 5, 2025, 2:00 PM

Transcript

IFF reports Q3 2025 results

IFF

Earnings

Share Buyback

Guidance Update

IFF delivered $2.7 billion in Q3 sales, flat year-over-year on a strong 9% prior-year comparable, and reported $519 million in adjusted operating EBITDA, up 7% with margin expanding 130 bps to 19.3%.
Year-to-date sales rose 2% and adjusted EBITDA grew 7%; gross debt fell by over $3 billion year-over-year, and net debt/credit-adjusted EBITDA stood at 2.5×.
Strategic investments included opening a scent creative center in Dubai, a citrus innovation center in Florida, expanding the Grasse naturals site, and advancing collaborations with BASF and Camira using DEB technology, with a major CPG launching a DEB-enhanced detergent.
IFF reiterated full-year 2025 guidance of $10.6 billion–$10.9 billion in sales and $2.0 billion–$2.15 billion in adjusted EBITDA, announced a $500 million share repurchase plan, and completed divestitures of Pharma Solutions and Nitrocellulose while moving to sell soy crush concentrates and lecithin.

Nov 5, 2025, 2:00 PM

Transcript

IFF reports Q3 2025 results

IFF

Earnings

Guidance Update

Share Buyback

Q3 2025 revenue was $2.694 billion, down 8% reported and flat on a comparable currency-neutral basis.
Q3 adjusted operating EBITDA reached $519 million, down 9% reported but up 7% on a comparable currency-neutral basis.
On a currency-neutral basis, Scent sales grew 5% (EBITDA +6%), Taste +2%/+2%, Food Ingredients –3% (EBITDA +24%) and Health & Biosciences 0% sales (+3% EBITDA) year-over-year.
9M YTD free cash flow was $126 million, net debt leverage improved to ~2.5x credit-adjusted EBITDA, and a $500 million share repurchase authorization was announced.
FY 2025 guidance reiterated: revenue of $10.6–10.9 billion (+1–4% CCN) and adjusted operating EBITDA of $2.0–2.15 billion, with expectations at the low end of the top-line range and mid-point of EBITDA.

Nov 5, 2025, 2:00 PM

Presentation

IFF reports Q3 2025 results

IFF

Earnings

Guidance Update

IFF reported net sales of $2.69 billion in Q3 2025, down 8% YoY but flat on a comparable currency-neutral basis.
Reported EPS was $0.16, with adjusted EPS ex-amortization of $1.05 per diluted share.
Adjusted operating EBITDA reached $519 million (19.3% margin), a 7% increase on a comparable currency-neutral basis.
The company reaffirmed full-year 2025 guidance: sales of $10.6 billion–$10.9 billion and adjusted operating EBITDA of $2.0 billion–$2.15 billion.

Nov 4, 2025, 9:21 PM

8-K

IFF announces strategic collaboration with BASF

IFF

New Projects/Investments

IFF and BASF announce a strategische samenwerking to accelerate next-generation enzyme and polymer innovation through IFF’s Designed Enzymatic Biomaterials™ technology platform for textiles, prepared meals, personal care and industrial cleaning.
The collaboration combines IFF’s biotechnological and protein engineering expertise with BASF’s advanced chemical capabilities to create high-performance, sustainable solutions that enhance cleaning efficacy, improve personal care formulations and reduce environmental impact.

Oct 21, 2025, 8:30 PM

Press Release

IFF announces strategic collaboration with BASF

IFF

New Projects/Investments

IFF (NYSE : IFF) and BASF have entered a strategic collaboration to accelerate development of IFF’s Designed Enzymatic Biomaterials™ platform and next-generation enzymatic technologies for textiles, dishwashing, personal care and industrial cleaning.
The partnership combines IFF’s biotechnology and protein-engineering expertise with BASF’s advanced chemical capabilities to deliver sustainable, high-performance solutions at scale.
Joint efforts will focus on enhancing cleaning performance, optimizing personal care formulations, reducing resource consumption and supporting environmental sustainability.
Both companies will maintain operational independence while leveraging complementary strengths to commercialize innovative enzymatic and biosourced polymer technologies.

Oct 21, 2025, 8:26 PM

Press Release

Earnings Transcripts

Quarterly earnings call transcripts for INTERNATIONAL FLAVORS & FRAGRANCES.

Ask Fintool AI Agent

Get instant answers from SEC filings, earnings calls & more

What did J. Erik Fyrwald say about margins?What are INTERNATIONAL FLAVORS & FRAGRANCES's strategic priorities?How is INTERNATIONAL FLAVORS & FRAGRANCES positioned vs competitors?How did INTERNATIONAL FLAVORS & FRAGRANCES do last quarter?

Let Fintool AI Agent track INTERNATIONAL FLAVORS & FRAGRANCES's earnings for you

Get instant analysis when filings drop